Cerebroprotection mediated by angiotensin II.
Ghali
Jalal K
JK
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D012107:Research Design; D020521:Stroke / Q000517:prevention & control*
D000319:Adrenergic beta-Antagonists; D001262:Atenolol